Clinical trial
A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
NCT00937326 is registered in ClinicalTrials.gov with Sirtris, a GSK Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
- Lead sponsor
- Sirtris, a GSK Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 19, 2009
- Completion date
- September 18, 2010
- Enrollment
- 227 (actual)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.